Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cells Article

Guo, Lei, Zhang, Lu, Sun, Yongming et al. (2006). Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cells . 10(3), 349-360. 10.1007/s11030-006-9038-0

Industry Collaboration

cited authors

  • Guo, Lei; Zhang, Lu; Sun, Yongming; Muskhelishvili, Levan; Blann, Ernice; Dial, Stacey; Shi, Leming; Schroth, Gary; Dragan, Yvonne P

sustainable development goals

authors

publication date

  • August 1, 2006

keywords

  • APOPTOSIS
  • Biochemistry & Molecular Biology
  • CANCER CELLS
  • Chemistry
  • Chemistry, Applied
  • Chemistry, Medicinal
  • Chemistry, Multidisciplinary
  • DIABETES-MELLITUS
  • IN-VITRO
  • JTT-501
  • LIVER-FAILURE
  • Life Sciences & Biomedicine
  • MICROARRAYS
  • NONCYCLIC 1,3-DICARBONYL COMPOUNDS
  • Pharmacology & Pharmacy
  • Physical Sciences
  • ROSIGLITAZONE
  • Science & Technology
  • THIAZOLIDINEDIONES
  • TROGLITAZONE
  • apoptosis
  • ciglitazone
  • cluster analysis
  • cytotoxicity
  • molecular descriptors
  • peroxisome proliferator-activated receptor gamma
  • pioglitazone
  • rat genome microarray
  • rat primary hepatocytes
  • rosiglitazone
  • troglitazone

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 349

end page

  • 360

volume

  • 10

issue

  • 3